SynthesisFrontiers in immunology2023

Outcomes with chimeric antigen receptor t-cell therapy in relapsed or refractory acute myeloid leukemia: a systematic review and meta-analysis.

Moazzam Shahzad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.